Hester Biosciences Limited — Others, 23-12-2024: Trading Window

Hester Biosciences has announced a closure of the trading window for its equity shares, effective 1 January 2025. This period will remain closed until 48 hours after the financial results for the quarter and nine months ended 31 December 2024 are publicly disclosed.

This move aligns with insider trading regulations and aims to ensure fair trading practices among directors and designated employees. Investors should note this development as it reflects the company's adherence to compliance measures, though it may create short-term constraints on trading activity. Overall, the impact appears neutral as it underscores a commitment to governance practices.